Deutsche Bank lowered the firm’s price target on Medpace to $336 from $395 and keeps a Hold rating on the shares. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on MEDP: Medpace bookings miss, guide-down challenge thesis, says UBS Medpace down 3% at $420 after Q2 results, guidance update Medpace raises FY24 EPS view to $11.24-$11.93 from $10.79-$11.47 Medpace reports Q2 EPS $2.75, consensus $2.54 MEDP Earnings Report this Week: Is It a Buy, Ahead of Earnings? Disclaimer & DisclosureReport an Issue